Xanthinol nicotinate supplier

Name
Xanthinol nicotinate
EINECS 207-115-7
CAS No. 437-74-1
Article Data4
CAS DataBase
Density
Solubility
Melting Point 180-184oC
Formula C₁₃H₂₁N₅O₄•C₆H₅NO₂
Boiling Point 589.3 °C at 760 mmHg
Molecular Weight 434.452
Flash Point 310.2 °C
Transport Information
Appearance White crystal or white crystal powder
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Landrina 300;Complamex;Complamin;7-[2-hydroxy-3-(2-hydroxyethyl-methyl-amino)propyl]-1,3-dimethyl-purine-2,6-dione; pyridine-3-carboxylic acid;3-Pyridinecarboxylic acid, compd. with 3, 7-dihydro-7-[2-hydroxy-3-[ (2-hydroxyethyl)methylamino]propyl]-1, 3-dimethyl-1H-purine-2,6-dione (1:1);Nicotinato de xantinol [INN-Spanish];SK 331A;Complamin retard;Stenalgil;Sadamine;Methoxylin, compd. with nicotinic acid;Vedrin;Xanthinol niacinate [USAN];Sadamin;Xantinoli nicotinas [INN-Latin];
PSA 155.71000
LogP -1.50150

Xanthinol nicotinate Specification

The xanthinol nicotinate , with the CAS register number 437-74-1, has the systematic name of pyridine-3-carboxylic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1) , and it has other names as 7-[2-hydroxy-3-(2-hydroxyethyl-methyl-amino)propyl]-1,3-dimethyl-purine-2,6-dione pyridine-3-carboxylic acid ; XANTINOL NICOTINATE ; XANTHINOL NICOTINATE ; 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophyllinecompd.withn ; 7-(3-(n-(2-hydroxyethyl)amino)-2-hydroxypropyl)thiophyllinenicotinate ; 7-[3-[(2-Hydroxyethyl)methylamino]-2-hydroxypropyl]theophyllinenicotinate ; amino)propyl)-1,3-dimethyl-1h-purine-2,6-dione ; angiomin .

The physical properties of this chemcial are as followings: (1)ACD/LogP: -0.20 ; (2)ACD/LogD (pH 5.5): -2.78 ; (3)ACD/LogD (pH 7.4): -1.09 ; (4)ACD/BCF (pH 5.5): 1 ; (5)ACD/BCF (pH 7.4): 1 ; (6)ACD/KOC (pH 5.5): 1 ; (7)ACD/KOC (pH 7.4): 2.41 ; (8)#H bond acceptors: 9 ; (9)#H bond donors: 2 ; (10)#Freely Rotating Bonds: 8 ; (11)Polar Surface Area: 80.14 ; (12)Flash Point: 310.2 °C ; (13)Enthalpy of Vaporization: 92.5 kJ/mol ; (14)Boiling Point: 589.3 °C at 760 mmHg ; (15)Vapour Pressure: 9.89E-15 mmHg at 25°C .

This is a kind of white crystalline powder and is soluble in water and acetic acid glacial , slightly soluble in the chloroform and anhydrous ethanol. As for its usage, it is usually used in Ischemic Cerebrovascular Disease, and sequel of apoplexy, such as cerebral thrombosis. Besides, it could be made vasodilator in many diseases, such as minimal brain dysfunction. If you need more safety information, you could refer to WGK Germany 2.

Below are the toxicity information of this chemical:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mammal (species unspecified)	LD50	intravenous	900mg/kg (900mg/kg)		Pharmaceutical Chemistry Journal Vol. 20, Pg. 286, 1986.
mouse	LD50	intravenous	673mg/kg (673mg/kg)		Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 21, Pg. 291, 1986.
mouse	LD50	oral	17350mg/kg (17350mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 601, 1975.
mouse	LD50	subcutaneous	4260mg/kg (4260mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 601, 1975.
rabbit	LD50	intravenous	500mg/kg (500mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 601, 1975.
rat	LD50	intraperitoneal	3010mg/kg (3010mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: CYANOSIS	Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 15, Pg. 424, 1968.
rat	LD50	intravenous	690mg/kg (690mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 601, 1975.
rat	LD50	oral	14130mg/kg (14130mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 601, 1975.
rat	LD50	subcutaneous	4061mg/kg (4061mg/kg)		Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 15, Pg. 424, 1968.

Product Name

Xanthinol nicotinate

Xanthinol nicotinate Specification

Related Products

Hot Products